8faacd8dbe8ce76d…
StudyID:
NCT00036114683 bytesFirst seen Jun 12, 20261 collectionFields
| Name | Value |
|---|---|
| briefSummary | The purpose of this study is to learn if aripiprazole is safe and effective in the treatment of psychosis associated with dementia of the Alzheimer's type. |
| completionDate | 2003-08 |
| conditions | ["Alzheimer Disease"] |
| enrollmentCount | null |
| enrollmentType | null |
| nctId | NCT00036114 |
| phase | PHASE3 |
| sponsorId | otsuka-pharmaceutical-development-commercialization-inc |
| startDate | 2000-03 |
| status | COMPLETED |
| studyType | INTERVENTIONAL |
| title | Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's Type |
| url | https://clinicaltrials.gov/study/NCT00036114 |
Canonical JSON
{
"id": "NCT00036114",
"type": "Study",
"data": {
"briefSummary": "The purpose of this study is to learn if aripiprazole is safe and effective in the treatment of psychosis associated with dementia of the Alzheimer's type.",
"completionDate": "2003-08",
"conditions": [
"Alzheimer Disease"
],
"enrollmentCount": null,
"enrollmentType": null,
"nctId": "NCT00036114",
"phase": "PHASE3",
"sponsorId": "otsuka-pharmaceutical-development-commercialization-inc",
"startDate": "2000-03",
"status": "COMPLETED",
"studyType": "INTERVENTIONAL",
"title": "Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's Type",
"url": "https://clinicaltrials.gov/study/NCT00036114"
}
}Appears in 1 collection
nih/clinical-trials1 version · Jun 12, 2026
Full hash:8faacd8dbe8ce76dd9a3801c31fa2f2a101ac9c18af411fdbc09520855fe9e6f